Biogen’s new Alzheimer’s drug to raise Medicare costs (NASDAQ:BIIB) Markets May 14, 2023 [ad_1] zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B -…
